Kiniksa Pharmaceuticals Ltd. Class A (KNSA) Financials

$77.91

$-2.56 (-3.18%)

As on 04-Sep-2026 18:14EDT

Market cap

$6,079 Mln

Revenue (TTM)

$841 Mln

P/E Ratio

78.7

P/B Ratio

9.6

Div. Yield

0 %

Annual
Quarterly

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	25.69	25.69	13.30	5.81	-126.30
Cash Flow from Investing Activities	--	37.67	37.67	-29.56	-8.08	128.64
Cash from Financing Activities	--	12.27	12.27	1.50	2.52	5.89
Net Cash Inflow / Outflow	--	--	--	--	0.25	8.22

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	1.00	0.75	-0.60	0.19	2.57	-2.29
Cash EPS ($)	--	0.77	-0.57	0.23	2.60	-2.26
Adjusted Book Value ($)	--	7.19	6.06	6.04	5.55	2.68
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	0.33	0.36	0.18	0.08	-1.83
Free Cash Flow per Share ($)	--	0.32	0.35	0.18	0.08	-2.13

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	11.51	-9.60	3.30	61.83	-61.93
ROE (%)	13.20	11.73	-9.85	3.37	63.10	-63.55
ROA (%)	8.74	8.78	-7.80	2.86	52.96	-54.24
EBIT Margin (%)	13.12	13.12	-8.54	-6.16	5.01	-406.38
Net Margin (%)	9.59	8.71	-10.21	5.21	82.81	-408.70
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	58.85	0.60	0.57	0.23	4.71	4.00
EBIT Growth (%)	673.39	345.82	-117.10	-251.02	107.04	0.46
Net Profit Growth (%)	1,583.88	236.61	-406.68	-92.32	216.11	2.14
EPS Growth (%)	2,323.43	2.25	-4.08	-0.92	2.12	0.03
Book Value Growth (%)	23.50	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	78.70	55.21	-33.12	90.49	5.83	-5.14
Price / Book Value	9.60	5.74	3.26	2.90	2.70	4.39
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	56.46	31.56	-34.73	-75.49	65.86	-4.12
Close Price ($)	63.95	41.25	19.78	17.54	14.98	11.77
High Price ($)	64.81	44.42	28.15	20.65	17.20	24.70
Low Price ($)	26.27	17.82	16.56	10.29	7.36	10.30
Market Cap ($ Cr)	6,078.85	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.02	0.02	0.03	0.01	0.03
Short term debt to equity ratio	0.01	0.01	0.00	0.01	0.01	0.02
Current Ratio	3.90	3.79	3.30	4.34	5.16	4.38
Quick Ratio	3.49	3.39	3.04	3.85	4.71	4.30
Interest Coverage	--	--	--	--	8.80	-63.88

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	2.79	2.30	9.86	7.87	9.23	10.34
Asset Turnover	0.91	1.01	0.76	0.55	0.64	0.13
Receivable days	--	15.45	27.18	28.10	20.16	18.88
Inventory Days	--	48.27	172.36	170.34	201.60	73.75
Payable days	--	2.42	30.84	52.16	77.91	47.58
Cash Conversion Cycle	--	61.31	168.70	146.27	143.85	45.05

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.